Transportation of sublingual antigens across sublingual ductal epithelial cells to the ductal antigen-presenting cells in mice

Clinical and Experimental Allergy

Volumn 45, Issue 3, 2015, Pages 677-686

  Nagai, Y ^a   Shiraishi, D ^a   Tanaka, Y ^a   Nagasawa, Y ^a   Ohwada, S ^a   Shimauchi, H ^a   Aso, H ^a   Endo, Y ^a   Sugawara, S ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

Antigen transportation; Sublingual ductal system; Sublingual immunotherapy

Indexed keywords

CD11B ANTIGEN; CD45 ANTIGEN; GLYCOPROTEIN P 15095; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; LATEX; OVALBUMIN; SILICON DIOXIDE; TRANSPLANTATION ANTIGEN; ALLERGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTING CELL; ARTICLE; CELL ISOLATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; EPITHELIUM CELL; ESCHERICHIA COLI; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBLINGUAL IMMUNOTHERAPY; ANIMAL; ANTIGEN PRESENTATION; CYTOLOGY; DESENSITIZATION; GASTROINTESTINAL ABSORPTION; IMMUNOLOGY; METABOLISM; SALIVARY GLAND DUCT; SUBLINGUAL DRUG ADMINISTRATION; TRANSPORT AT THE CELLULAR LEVEL;

ADMINISTRATION, SUBLINGUAL; ALLERGENS; ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; BIOLOGICAL TRANSPORT; DESENSITIZATION, IMMUNOLOGIC; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; MICE; ORAL MUCOSAL ABSORPTION; SALIVARY DUCTS;

EID: 84923388346     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12329     Document Type: Article

References (24)

1. Dahl R, Kapp A, Colombo G et al. Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years. J Allergy Clin Immunol 2008; 121:512-18. e2.
2. Ott H, Sieber J, Brehler R et al. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study. Allergy 2009; 64:1394-401.
3. Wilson DR, Lima MT, Durham SR. Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis. Allergy 2005; 60:4-12.
4. + T cells. J Allergy Clin Immunol 2008; 122:603-9. e5.
5. Savolainen J, Jacobsen L, Valovirta E. Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC. Allergy 2006; 61:1184-90.
6. Ciprandi G, Fenoglio D, Cirillo I, Milanese M, Minuti P. Sublingual immunotherapy and regulatory T cells. Allergy 2006; 61:511-13.
7. Akdis CA, Barlan IB, Bahceciler N, Akdis M. Immunological mechanisms of sublingual immunotherapy. Allergy 2006; 61(Suppl 81):11-14.
8. Piconi S, Trabattoni D, Rainone V et al. Immunological effects of sublingual immunotherapy: clinical efficacy is associated with modulation of programmed cell death ligand 1, IL-10, and IgG4. J Immunol 2010; 185:7723-30.
9. Novembre E, Galli E, Landi F et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 2004; 114:851-7.
10. Lima MT, Wilson D, Pitkin L et al. Grass pollen sublingual immunotherapy for seasonal rhinoconjunctivitis: a randomized controlled trial. Clin Exp Allergy 2002; 32:507-14.
11. Cuburu N, Kweon MN, Hervouet C et al. Sublingual immunization with nonreplicating antigens induces antibody-forming cells and cytotoxic T cells in the female genital tract mucosa and protects against genital papillomavirus infection. J Immunol 2009; 183:7851-9.
12. Allam JP, Bieber T, Novak N. Dendritic cells as potential targets for mucosal immunotherapy. Curr Opin Allergy Clin Immunol 2009; 9:554-7.
13. Song JH, Kim JI, Kwon HJ et al. CCR7-CCL19/CCL21-regulated dendritic cells are responsible for effectiveness of sublingual vaccination. J Immunol 2009; 182:6851-60.
14. Allam JP, Peng WM, Appel T et al. Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells. J Allergy Clin Immunol 2008; 121:368-74. e1.
15. Sun JB, Flach CF, Czerkinsky C, Holmgren J. B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit. J Immunol 2008; 181:8278-87.
16. Hovav AH. Dendritic cells of the oral mucosa. Mucosal Immunol 2014; 7:27-37.
17. Brook I. The bacteriology of salivary gland infections. Oral Maxillofac Surg Clin North Am 2009; 21:269-74.
18. Allam JP, Stojanovski G, Friedrichs N et al. Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? Allergy 2008; 63:720-7.
19. Mascarell L, Saint-Lu N, Moussu H et al. Oral macrophage-like cells play a key role in tolerance induction following sublingual immunotherapy of asthmatic mice. Mucosal Immunol 2011; 4:638-47.
20. Denning TL, Wang YC, Patel SR, Williams IR, Pulendran B. Lamina propria macrophages and dendritic cells differentially induce regulatory and interleukin 17-producing T cell responses. Nat Immunol 2007; 8:1086-94.
21. Nochi T, Yuki Y, Takahashi H et al. Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines. Nat Mater 2010; 9:572-8.
22. Kiyono H, Fukuyama S. NALT- versus Peyer's-patch-mediated mucosal immunity. Nat Rev Immunol 2004; 4:699-710.
23. Nagatake T, Fukuyama S, Kim DY et al. Id2-, RORγt-, and LTβR-independent initiation of lymphoid organogenesis in ocular immunity. J Exp Med 2009; 206:2351-64.
24. Ménard S, Cerf-Bensussan N, Heyman M. Multiple facets of intestinal permeability and epithelial handling of dietary antigens. Mucosal Immunol 2010; 3:247-59.